Biopsy is expected to remain the most lucrative cancer diagnostics test due to technological advancements such as fine needle aspiration The biopsy test type segment dominated the global cancer diagnostics market in revenue terms in…
According to a new report, the global cancer diagnostics market is anticipated to grow at 8.9% CAGR during the forecast period 2016-2026. The market was valued at over US$ 32 Bn in 2016, and it…
Cancer is characterized by the growth of abnormal cells that divide uncontrollably and have the ability to infiltrate and destroy normal body tissue. Cancer is triggered by both external factors such as tobacco, chemicals, alcohol,…
